Mycobacterial Diseases waives off up to 50% of its article processing charges of Mycobacterial Diseases during open access week (21-27 October, 2019).
Online PR News – 24-October-2019 – Brussels, Belgium – Mycobacterial Diseases ISSN: 2161-1068 Celebrates Open Access Week (21-27 October, 2019)
Mycobacterial Diseases celebrates more than a decade of its existence in the field of clinical publishing and research and extends a very warm welcome to all the authors, researchers, editors and student to contribute their latest research findings as full length articles to this collaborative health journal. The journal is committed to serve its readers authors by adding the state of the art facilities to enhance the author's scholarly visibility.
Established in the year 2011, Mycobacterial Diseases is one of the most reputed journals of Longdom group, the medical publisher, known for its close-knit association with medical societies and agencies engaged in medical research. The journal has been publishing the most recent developments in the fields of Mycobacterial Diseases, Antimycobacterial therapy, Atypical mycobacteria, Bacterial pathogenesis, Clinical mycobacteriology, Molecular bacteriology, Mycobacteria, Mycobacterial diseases, Mycobacterial genetics, Mycobacterial immunology, Mycobacterial pharmacology, Mycobacterial toxicity, Mycobacterial virulence, Mycobacterium bovis, Mycobacterium leprosy, Pericardial tuberculosis and creates a platform for the authors to contribute towards the journal. The scope of the journal is not limited to the listed research areas but covers a lot more areas globally as full length research articles and case studies.
Not with standing to any specific field, the journal has so far published voluminous issues on aging and other issues, challenges and therapeutic solutions to various fields.
Under the able stewardship of David A. Hokey, from Areas Global TB Vaccine Foundation, USA as an Editor-in-Chief, world renowned researchers, scientists, and academicians including an Executive Editor Haruaki Tomioka, from Shimane University School of Medicine, Japan, Gerd Pluschke, from Swiss Tropical and Public Health Institute, Switzerland, Deepak Kaushal, from Tulane University School of Medicine, USA, Subramanian Dhandayuthapani, from The University of Texas Health Science Center, USA, Gobardhan Das, from University of Kwazulu-Natal, South Africa, Mochammad Hatta, from Hasanuddin University, Indonesia, Demelash Biffa Areda, from The University of Arizona, USA, Delia Goletti, from National Institute for Infectious Diseases, Italy, Keertan Dheda, from University of Cape Town, South Africa, Horacio Bach, from The University of British Columbia, Canada, Alfred Allan Duker, from Kwame Nkrumah University of Science and Technology, Ghana, Hui-Qi Qu, from University of Texas Health Science Center at Houston, USA, Pitchai Balakumar, from Rajendra Institute of Technology and Sciences, India, Nadeem A. Ansari, from Banaras Hindu University, India are acting as editorial board members to add significant value to the research in the field of bacterial diseases.
Listed and indexed in the reputed indexing sites like RefSeek, Hamdard University, Publons the Mycobacterial Diseases is committed to 'Creative Commons' policy of publishing the scholarly articles on open access forum, after a thorough peer review. The journal is enjoying the staunch support of Longdom, a faithful publisher committed to medical science research.
Established in 2008, the Longdom Group has become an ultimate destination to the world-class, peer-review health journals till date. Longdom medical publications are highly respected by physicians, surgeons, practitioners, and researchers alike and thus become an essential part of the international medical landscape for publishing scientific literature, which is critical to the research cycle.
On the eve completing more than a decade in medical publishing, the Mycobacterial Diseases waives off up to 50% of its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of mycobacterial diseases during open access week (21-27 October, 2019).